To evaluate module R22 as a diagnostic AOA2 biomarker, we utilized the WGCNA module preservation function to discern whether module R22 could effectively distinguish broadly between the expression profiles of AOA2 and those of other neurodegenerative diseases. This evidence concerns the gene SETX and neurodegenerative disease.